Expression of Concern
This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.
This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.
Research Paper Volume 11, Issue 22 pp 10266—10283
Silencing lncRNA FOXD2-AS1 inhibits proliferation, migration, invasion and drug resistance of drug-resistant glioma cells and promotes their apoptosis via microRNA-98-5p/CPEB4 axis
Figure 1. Highly expressed FOXD2-AS1 is found in glioma. (A) The expression level of FOXD2-AS1 in glioma tumor tissues and corresponding para normal tissues was detected by RT-qPCR (N = 68); (B) RT-qPCR was used to detect the expression of FOXD2-AS1 in human normal glial brain cell line HEB and 4 human glioma cell lines. * P < 0.05 vs human normal glial brain cell line HEB. The data were all measurement data, represented by mean ± standard deviation. The comparison between the two groups was statistically analyzed by independent sample t test, and one-way ANOVA was used in comparisons among multiple groups, and Tukey’s post-hoc test was performed after ANOVA. The experiment was repeated three times.